71 results
8-K
EX-10.1
ZIVO
ZIVO Bioscience, Inc.
22 Nov 23
Entry into a Material Definitive Agreement
4:21pm
, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys’ fees and costs of defense and investigation), amounts paid … , claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other
8-K
EX-4.2
ZIVO
ZIVO Bioscience, Inc.
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
' fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition
8-K
EX-4.1
ZIVO
ZIVO Bioscience, Inc.
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing
8-K
EX-1.1
9czhys1
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
8-K
EX-10.1
r5cx6v 6r8
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
8-K
EX-4.3
ues lraona857bql0
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
8-K
EX-10.1
erwbjv
5 Apr 23
ZIVO Bioscience Receives $1 Million Bridge Financing
4:15pm
8-K
EX-3.1
envkem 6gbms
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:33pm
8-K
EX-99.1
4v33 c32n
11 Jan 22
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
12:00am
8-K
EX-1.1
8lbi ngsj2alu
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
8-K
EX-99.2
7lz5 axuod0fm
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
8-K
EX-4.2
749qdtnu
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
8-K
EX-99.1
gwd kx94c
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
8-K
EX-4.1
nwb2ykeb8ybid6mg22
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
S-1MEF
EX-5.2
yrw1u6 bgya
27 May 21
Registration of additional securities for an S-1
8:17pm